B O O K - American College of Rheumatology

5:45 PM
699. Defining Latent and/or Disseminated Active Tuberculous
Infection with TST, Quantiferon Gold and Multisite Cultures in
TNFi Exposed Individuals.
Dilrukshie Cooray 2 , James S. Louie 4 , Rosalinda C. Moran 1 and
George A. Karpouzas 3 , 1 Harbor- UCLA Medical Center, Carson,
CA, 2 Harbor-UCLA Medical Center, Torrance, CA, 3 Harbor-UCLA
Medical Center, Long Beach, CA, 4 University of California Los
Angeles, Los Angeles, CA
A404
Miscellaneous Rheumatic and Inflammatory Diseases
Moderators: W. Winn Chatham, MD; University of Alabama-
Birmingham; Birmingham, AL
Kristine M. Lohr, MD, MS; Kentucky Clinic; Lexington, KY
4:30 PM
700. Progressive Multifocal Leukoencephalopathy Associated
with Biologic and Synthetic DMARD Therapy in Rheumatic
Diseases: An Analysis of the FDA Adverse Event Reporting
System Database.
Eamonn S. Molloy 2 and Leonard H. Calabrese 1 , 1 Cleveland Clinic
Foundation, Cleveland, OH, 2 St Vincent’s University Hospital,
Dublin, Ireland
4:45 PM
701. Tocilizumab in Refractory Adult Still’s Disease: A Cohort
Study.
Xavier Puéchal, Michel de Bandt, Jean-Marie Berthelot, Maxime
Breban, Jean-Jacques Dubost, Olivier Fain, Jean-Emmanuel Kahn,
Laurence Lequen, Maïté Longy-Boursier, Aleth Perdriger, Thierry
Schaeverbeke, Eric Toussirot, Jean Sibilia and The CRI, Center
for Rare Systemic and Auto-immune Diseases, Department of
Rheumatology, Le Mans, France
5:00 PM
702. Clinical Implications of the NMO-IgG Antibody and
Overlapping Neuromyelitis Optica Spectrum Disorder in
Patients with Connective Tissue Disease and Myelitis.
Jason R. Kolfenbach 1 , Brian J. Horner 3 and Sterling G. West 2 ,
1
Division of Rheumatology, University of Colorado at Denver,
Aurora, CO, 2 University of Colorado at Denver, Aurora, CO,
3
University of Colorado Denver School of Medicine
5:15 PM
703. Diagnostic Significance of Serum Interleukin-18 Level in
Adult-Onset Still’s Disease.
Junko Maruyama 3 , Shigeko Inokuma 1 and Noboru Hagino 2 ,
1
Japanese Red Cross Medical Center, 2 The University of Tokyo
Hospital, 3 Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
5:30 PM
704. Extrapulmonary Course of Connective Tissue Disease and
Survival after Lung Transplant.
Troy K. Takagishi, Iffat Ahmed and Rodney Tehrani, Loyola
University Medical Center
5:45 PM
705. Idiopathic Retroperitoneal Fibrosis: Treatment-Related
Outcomes and Predictors of Clinical Response.
Tanaz A. Kermani 1 , Cynthia S. Crowson 2 , Sara Achenbach 2 and
Harvinder S. Luthra 1 , 1 Mayo Clinic, Rochester, MN, 2 Mayo Clinic
A314
Osteoarthritis - Clinical Aspects: Genetics, Novel
Approaches, and Therapy
Moderators: Timothy E. McAlindon, MD, MPH; Tufts Medical
Center; Boston, MA
Tuhina Neogi, MD, PhD; Boston University School of Medicine;
Boston, MA
4:30 PM
706. Clinical Trial of Vitamin D To Reduce Pain and Structural
Progression of Knee Osteoarthritis (OA).
Timothy E. McAlindon 3 , Bess Dawson-Hughes 5, Jeffrey Driban 4 ,
Michael LaValley 2 , Ji Yeon Lee 4 , Grace H. Lo 1 , Melynn Nuite 4 and
Lori Lyn Price 4 , 1 Baylor College of Medicine, 2 Boston University
School of Public Health, 3 Tufts Medical Center, Boston, MA,
4
Tufts Medical Center, 5 USDA HNRC; Tufts University
4:45 PM
707. Interleukin-1 Receptor Antagonist (IL-1RN) Gene
Variations Predict the Severity and Progression of Knee
Osteoarthritis.
Mukundan Attur 8 , Cheongun Oh 7 , Svetlana Krasnokutsky 6 ,
Jonathan Samuels 5 , Leon Rybak 9 , Jenny Bencardino 9 , Jeffrey
D. Greenberg 1 , Virginia Kraus 2 , Kenneth Kornman 4 and Steven
B. Abramson 3 , 1 Millburn, NJ, 2 Duke University Medical Center,
Durham, NC, 3 Hospital for Joint Dis/NYU, New York, NY,
4
Interleukin Genetics, 5 New York University Hospital for Joint
Disease, New York, NY, 6 NYU Hospital for Joint Disease, New
York, NY, 7 NYU-Hospital for Joint Diseases, 8 NYU-Hospital for
Joint Diseases, New York, NY, 9 NYU-Hospital for Joint Diseases
Radiology Dept.
5:00 PM
708. Hand Osteoarthritis (OA) a Predictor of Accelerated
Progression in Knee OA?
Jonathan Samuels 3 , Catherine Petchprapa 6 , Elizabeth L.
Carpenter 6 , Svetlana Krasnokutsky 4 , Mukundan Attur 2 , Leon
Rybak 5 , Jenny Bencardino 5 , Cheongeun Oh 6 and Steven B.
Abramson 1 , 1 Hospital for Joint Dis/NYU, New York, NY, 2 Hospital
for Joint Dis/NYU Langone Medical Center, 3 New York University
Hospital for Joint Disease, New York, NY, 4 NYU Hospital for Joint
Disease, New York, NY, 5 NYU Hospital for Joint Diseases, 6 NYU
Langone Medical Center
5:15 PM
709. Bone Marrow Lesions (BMLs) Are Strongly Associated with
Increased Bone Volume Fraction; “Virtual Bone Biopsy” Using
MRI.
Anna M. Tassinari 3 , Grace H. Lo 1 , Jeffrey Driban 3 , Lori Lyn Price 3 ,
Erika Schneider 2 and Timothy E. McAlindon 3 , 1 Baylor College of
Medicine, Houston, TX, 2 The Cleveland Clinic, Cleveland, OH,
3
Tufts Medical Center, Boston, MA
5:30 PM
710. REGN475/SAR164877, a Nerve Growth Factor Inhibitor,
in Osteoarthritis Patients with Moderate to Severe Knee Pain:
Results of a Phase 2, Randomized, Double-Blind, Placebo-
Controlled Study.
Paul Tiseo 4 , Alan J. Kivitz 1 , John E. Ervin 2 , Scott J. Mellis 3 ,
Haobo Ren 4 , Damir Skific 4 , Richard Wu 4 and Peter Powchik 4 ,
1
Altoona Arthritis & Osteo Ctr, Duncansville, PA, 2 Center
for Pharmaceutical Res, Kansas City, MO, 3 Regeneron
Pharmaceuticals, Inc., Tarrytown, NY, 4 Regeneron
Pharmaceuticals, Inc.
2010 Program Book 49
monday